Big Pharma
At ManiFiesta, a different health system is no mere vision

At ManiFiesta, the fest of solidarity, Medics for the People sparked discussions about pressing problems in the health system in Belgium, offering people-centered, public alternatives

Scientists call upon European Union to build public pharma production capacities

Dozens of scientists, health activists, and health officers in the EU are gathering support for building public capacities for pharmaceutical production and breaking ties with industry

Health movement in South Korea fights for universal access to medicines

Civil society in South Korea renewed its commitment to ensure universal access to medicines and public pharmaceutical production, building on decades of mobilization

Access to health summit Access to medicines summit urges for more decisive action against Big Pharma domination

Activists and academics discussed future of the access to medicines movement at the Global Summit on Intellectual Property and Access to Medicines in Istanbul at the end of July

Medics for the People Belgium Medics for the People has a radical plan to rebuild healthcare in Belgium and Europe

Medics for the People has been providing primary health care to people in Belgium for more than 50 years. They recently launched a new mission statement outlining their main streams of work for the upcoming period

Importance of TRIPS flexibilities under the Doha Declaration on Public Health

NewscClick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the TRIPS waiver and the larger question of intellectual property rights and public health

Jeremy Corbyn: It’s not enough to resist—we have to build, too

We don’t face multiple separate crises. The system itself is the crisis and must be overcome, replaced and transformed.

African Medicine Agency Push for more regulation and ‘quality controls’ may further complicate medicine supply in Africa  

The creation of the African Medicines Agency with the objective of maintaining European standards for medicines in the continent may hamper the supply of regular and economical versions of medicines in areas where access is already skewed 

Patents, profits and squabbles for share in the pie – Moderna’s pandemic story

Moderna’s filing for patents in South Africa puts a question mark on its intentions of honoring the pledge that it will not enforce patents during the pandemic. Activists fear that this may jeopardize the WHO’s technology sharing hub

The people of the world vs Pfizer Inc.

During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment

Not Omicron but greed of capital threatens the world

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn